Tag: Dr Reddy’s

The Dr. Anji Reddy Memorial Lecture is an annual lecture series instituted in 2023 to honour Founder-Chairman Dr. K. Anji Reddy’s passion for deep science and innovation

Beyfortus® (nirsevimab) is the first monoclonal antibody approved to protect all infants born during or entering their 1st Respiratory Syncytial Virus (RSV) season

These institutions, run by the state government, provide education to 480 school students and 160 college students, primarily girls from tribal areas across the state

The Cover Story tracks the strides made by the Indian biotech industry towards sustainability goals. Special interview of Shivaji Dashrath Jadhav, Vice President & Head - EHS & Sustainability, Aragen Life Sciences. Expert Insights by Vikrant Agrawal, Co-founder, Care.fi and Rajeev Taneeja, Founder and CEO, Global Care. Special stories on bio-manufacturing, healthcare innovation and agri-foodtech.

Industry captains  and regulators in the ecosystem deliberate on achieving excellence and quality in operations, vaccine development and sustainability

The arrangement brings together the manufacturing and development synergies of Novartis India Limited with the sales and distribution strengths of Dr. Reddy’s Laboratories

The investment has been made with a view to develop a world-class pharmaceutical supply chain & distribution IT ecosystem and support the government’s National Digital Health Mission.............................

Recently, Bharat Biotech has applied for regulatory approval to conduct clinical trials in Bangladesh and has applied for EUA in the Philippines.....................

The clinical trials are being conducted by JSS Medical Research as a clinical research partner...................

As a result of the termination, the Indian drug maker has regained worldwide rights to DFA-02, and is currently evaluating its options to take the programme forward...………..